Laurion Capital Management’s Charles River Laboratories CRL Stock Holding History

Laurion Capital Management’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,207	Closed	-$248K	–	1235
2018 Q2	$248K	Buy	2,207 +307	+16%	+$33.2K	﹤0.01%	1148
2018 Q1	$203K	Buy	+1,900	New	+$205K	﹤0.01%	1227
2017 Q3	–	Sell	-11,500	Closed	-$1.16M	–	1614
2017 Q2	$1.16M	Buy	+11,500	New	+$1.06M	0.01%	978
2017 Q1	–	Sell	-4,032	Closed	-$307K	–	1334
2016 Q4	$307K	Buy	4,032 +1,300	+48%	+$98.7K	﹤0.01%	927
2016 Q3	$228K	Buy	2,732 +200	+8%	+$16.8K	﹤0.01%	767
2016 Q2	$209K	Buy	+2,532	New	+$209K	﹤0.01%	738

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return

Laurion Capital Management's CRL Position: Q3 2018 in Review

Laurion Capital Management sold out of Charles River Laboratories (CRL) in Q3 2018, closing a stake of 2,207 shares — an estimated $248K sold.

Laurion Capital Management first reported a position in CRL in Q2 2016 and held it in 6 quarters. The position peaked at $1.16M in Q2 2017. 366 funds tracked by Wall St. Rank hold CRL as of Q3 2018.

Laurion Capital Management reported no remaining Charles River Laboratories position as of Q3 2018 after selling out during the quarter.
Laurion Capital Management sold 2,207 Charles River Laboratories shares in Q3 2018, an estimated $248K.
Laurion Capital Management first reported a position in Charles River Laboratories in Q2 2016 and held it in 6 quarters.
Laurion Capital Management's Charles River Laboratories position peaked at $1.16M in Q2 2017.
366 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2018.

Based on Laurion Capital Management's 13F filing for Q3 2018, filed 13 Nov 2018.